<DOC>
	<DOCNO>NCT00508898</DOCNO>
	<brief_summary>Glomerulonephritis renal failure represent one life-threatening manifestation systemic lupus erythematosus ( SLE ) . Although immunosuppressive therapy often effective treatment acute lupus nephritis , significant proportion patient show persistent proteinuria resolution acute nephritic process , develop progressive renal failure . There preliminary evidence calcitriol vitamin D analog reduce proteinuria patient chronic kidney disease . The investigator plan conduct randomize control study evaluate safety efficacy calcitriol treatment SLE patient persistent proteinuria . Sixty patient clinically quiescent SLE persistent proteinuria despite conventional therapy recruit . They treat calcitriol 48 week . Proteinuria , renal function , lupus disease activity , serum urinary inflammatory marker monitor . This study explore potential anti-proteinuric immunomodulating effect calcitriol treatment SLE , common life threaten disease young adult .</brief_summary>
	<brief_title>The Efficacy Safety Calcitriol Treatment Lupus Nephritis Persistent Proteinuria</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>age 1865 year clinical quiescent SLE least 12 week baseline SLEDAI score &lt; = 4 history biopsyproven lupus nephritis estimate glomerular filtration rate 15 60 ml/min/1.73m2 proteinuria &gt; 1 g/day ( proteinuria &gt; 1 g/gCr ) 2 consecutive sample within 12 week despite ACE inhibitor angiotensin receptor blocker least 3 month maintenance dose prednisolone &lt; 10 mg/day , without immunosuppressive medication correct serum calcium level &lt; 2.45 mmol/l willingness give write consent comply study protocol Pregnancy , lactate childbearing potential without effective method birth control Severe gastrointestinal disorder interfere ability receive absorb oral medication History malignancy , include leukemia lymphoma within past 2 year Systemic infection require therapy study entry Any severe coexisting disease , limited , chronic liver disease , myocardial infarction , cerebrovascular accident , malignant hypertension History drug alcohol abuse within past 2 year Participation previous trial vitamin D analogue Patients receive treatment vitamin D and/or analogue medical reason within past 4 week . Patients take multivitamin supplement contain vitamin D could enrol 4 week wash period change preparation vitamin D. On investigational drug within last 30 day History psychological illness condition interfere patient 's ability understand requirement study History noncompliance Known history sensitivity allergy vitamin D analog</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>lupus nephritis</keyword>
	<keyword>proteinuria</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>SLE</keyword>
</DOC>